- Home
- CRVO vs YSXT Comparison
CRVO vs YSXT Comparison
Compare CRVO & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- YSXT
- Stock Information
- Founded
- CRVO 2001
- YSXT 2011
- Country
- CRVO United States
- YSXT China
- Employees
- CRVO N/A
- YSXT N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- YSXT Automotive Aftermarket
- Sector
- CRVO Health Care
- YSXT Consumer Discretionary
- Exchange
- CRVO Nasdaq
- YSXT Nasdaq
- Market Cap
- CRVO 98.3M
- YSXT 87.9M
- IPO Year
- CRVO N/A
- YSXT 2024
- Fundamental
- Price
- CRVO $2.11
- YSXT $4.66
- Analyst Decision
- CRVO Buy
- YSXT
- Analyst Count
- CRVO 8
- YSXT 0
- Target Price
- CRVO $38.75
- YSXT N/A
- AVG Volume (30 Days)
- CRVO 303.4K
- YSXT 235.9K
- Earning Date
- CRVO 11-12-2024
- YSXT 01-01-0001
- Dividend Yield
- CRVO N/A
- YSXT N/A
- EPS Growth
- CRVO N/A
- YSXT N/A
- EPS
- CRVO N/A
- YSXT 0.21
- Revenue
- CRVO $10,066,550.00
- YSXT $58,546,729.00
- Revenue This Year
- CRVO $34.17
- YSXT N/A
- Revenue Next Year
- CRVO N/A
- YSXT N/A
- P/E Ratio
- CRVO N/A
- YSXT $22.45
- Revenue Growth
- CRVO 116.29
- YSXT 18.92
- 52 Week Low
- CRVO $1.80
- YSXT $2.54
- 52 Week High
- CRVO $26.38
- YSXT $6.27
- Technical
- Relative Strength Index (RSI)
- CRVO 28.68
- YSXT N/A
- Support Level
- CRVO $2.03
- YSXT N/A
- Resistance Level
- CRVO $2.17
- YSXT N/A
- Average True Range (ATR)
- CRVO 0.16
- YSXT 0.00
- MACD
- CRVO 0.30
- YSXT 0.00
- Stochastic Oscillator
- CRVO 23.08
- YSXT 0.00
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.